Skip to main content

Table 2 CRS and HIPEC procedures performed in 53 patients with (n = 21) or without (n = 32) “neoajuvant” PIPAC

From: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Patients All
(n = 53)
Primary CRS and HIPEC
(n = 32)
Secondary CRS and HIPEC (after PIPAC)
(n = 21)
Number of CRS and HIPEC
 -Single procedure
 -Repeated HIPEC
57
53
4
36
32
4
21
21
0
Completeness of cytoreduction (CC) score
 -CC-0
 -CC-1
 -CC-2
39 (74 %)
12 (22 %)
2 (4 %)
22 (69 %)
9 (28 %)
1 (3 %)
17 (81 %)
3 (14 %)
1 (5 %)
Number of PIPAC before HIPEC
 1
 2
 3
 4
 5
12
0
4
4
1
N/A
N/A
N/A
N/A
N/A
12
0
4
4
1
Downstaginga
 -Histology
 -Radiology
N/A
N/A
N/A
N/A
8/9
7/9
  1. N/A non available
  2. aOut of nine patients with ≥2 PIPAC